Company Ablynx CBOE EUROPE EQUITIES
Equities
0HNK
BE0003877942
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2018 | AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit | RE |
2018 | Sanofi : sees new acquisitions and drugs reviving growth | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Petrus Houwen
CEO | Chief Executive Officer | - | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 19-03-31 | |
Pieter Oldenziel
BRD | Director/Board Member | - | 18-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,001,392 | 77,221,378 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- ABLX Stock
- 0HNK Stock
- Company Ablynx